BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Garcovich M, Zocco MA, Roccarina D, Ponziani FR, Gasbarrini A. Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota. World J Gastroenterol 2012; 18(46): 6693-6700 [PMID: 23239905 DOI: 10.3748/wjg.v18.i46.6693]
URL: https://www.wjgnet.com/1007-9327/full/v18/i46/6693.htm
(0) (0) (17868) (47)
Number Citing Articles
1
Alba Moratalla, Javier Ampuero, Pablo Bellot, Rocío Gallego‐Durán, Pedro Zapater, Manuela Roger, Blanca Figueruela, Belén Martínez‐Moreno, José M. González‐Navajas, José Such, Manuel Romero‐Gómez, Rubén Francés. Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy. Liver International 2017; 37(2) doi: 10.1111/liv.13200
2
Gregory P. Donaldson, S. Melanie Lee, Sarkis K. Mazmanian. Gut biogeography of the bacterial microbiota. Nature Reviews Microbiology 2016; 14(1) doi: 10.1038/nrmicro3552
3
Zeeshan Butt, Nauman A. Jadoon, Osman N. Salaria, Kamran Mushtaq, Irbaz B. Riaz, Ahmed Shahzad, Ali M. Hashmi, Shahid Sarwar. Diabetes mellitus and decompensated cirrhosis: Risk of hepatic encephalopathy in different age groups (糖尿病与失代偿性肝硬化：不同年龄组的肝性脑病风险). Journal of Diabetes 2013; 5(4) doi: 10.1111/1753-0407.12067
4
Lan-Jing Wang, Xin Yao, Qi Qi, Jian-Ping Qin. Prevention and treatment of hepatic encephalopathy during the perioperative period of transjugular intrahepatic portosystemic shunt. World Journal of Gastrointestinal Surgery 2023; 15(8): 1564-1573 doi: 10.4240/wjgs.v15.i8.1564
5
David W. Victor, Eamonn M.M. Quigley. Hepatic Encephalopathy Involves Interactions Among the Microbiota, Gut, Brain. Clinical Gastroenterology and Hepatology 2014; 12(6) doi: 10.1016/j.cgh.2014.01.022
6
Rajan Singh, Hannah Zogg, Lai Wei, Allison Bartlett, Uday C Ghoshal, Singh Rajender, Seungil Ro. Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders. Journal of Neurogastroenterology and Motility 2021; 27(1) doi: 10.5056/jnm20149
7
Jingjing Li, Zujiang Yu, Qiongye Wang, Duolu Li, Bin Jia, Yubing Zhou, Yanwei Ye, Shen Shen, Yanfang Wang, Shasha Li, Lu Bai, Quancheng Kan. Hyperammonia induces specific liver injury through an intrinsic Ca2+-independent apoptosis pathway. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-151
8
Pavlo Petakh, Valentyn Oksenych, Iryna Kamyshna, Iryna Boisak, Katerina Lyubomirskaya, Oleksandr Kamyshnyi. Exploring the complex interplay: gut microbiome, stress, and leptospirosis. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1345684
9
Xueyan Lin, Zhengchao Zhang, Yi Lin, Shiyun Lu, Rongrong Chen, Wan-Long Chuang. The effects of rifaximin and lactulose on the gut-liver-brain axis in rats with minimal hepatic encephalopathy. PLOS One 2025; 20(6) doi: 10.1371/journal.pone.0325988
10
Xiao Wei, Shan Jiang, Xiangna Zhao, Huan Li, Weishi Lin, Boxing Li, Jing Lu, Yansong Sun, Jing Yuan. Community-Metabolome Correlations of Gut Microbiota from Child-Turcotte-Pugh of A and B Patients. Frontiers in Microbiology 2016; 7 doi: 10.3389/fmicb.2016.01856
11
Philipp Schindler, Leon Seifert, Max Masthoff, Arne Riegel, Michael Köhler, Christian Wilms, Hartmut H. Schmidt, Hauke Heinzow, Moritz Wildgruber. TIPS Modification in the Management of Shunt-Induced Hepatic Encephalopathy: Analysis of Predictive Factors and Outcome with Shunt Modification. Journal of Clinical Medicine 2020; 9(2) doi: 10.3390/jcm9020567
12
Lauren R. Heinzinger, Angus Johnson, Jenna I. Wurster, Rachael Nilson, Swathi Penumutchu, Peter Belenky. Oxygen and Metabolism: Digesting Determinants of Antibiotic Susceptibility in the Gut. iScience 2020; 23(12) doi: 10.1016/j.isci.2020.101875
13
Suraphan Panyod, Wei-Kai Wu, Kuan-Hung Lu, Chun-Ting Liu, Yung-Lin Chu, Chi-Tang Ho, Wen-Luan Wendy Hsiao, Yi-Syuan Lai, Wei-Cheng Chen, Yu-En Lin, Shi-Hang Lin, Ming-Shiang Wu, Lee-Yan Sheen. Allicin Modifies the Composition and Function of the Gut Microbiota in Alcoholic Hepatic Steatosis Mice. Journal of Agricultural and Food Chemistry 2020; 68(10) doi: 10.1021/acs.jafc.9b07555
14
J. S. Bajaj. Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis. Alimentary Pharmacology & Therapeutics 2016; 43(S1) doi: 10.1111/apt.13435
15
Jasmohan S. Bajaj, Giovanni Barbara, Herbert L. DuPont, F. Mearin, Antonio Gasbarrini, Jan Tack. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases. Digestive and Liver Disease 2018; 50(8) doi: 10.1016/j.dld.2018.04.020
16
Jérémie Jacques, Paul Carrier, Marilyne Debette-Gratien, Rodolphe Sobesky, Véronique Loustaud-Ratti. Encéphalopathie hépatique. La Presse Médicale 2016; 45(1) doi: 10.1016/j.lpm.2015.02.021
17
Arumugam R. Jayakumar, Xiao Y. Tong, Kevin M. Curtis, Roberto Ruiz‐Cordero, Maria T. Abreu, Michael D. Norenberg. Increased toll‐like receptor 4 in cerebral endothelial cells contributes to the astrocyte swelling and brain edema in acute hepatic encephalopathy. Journal of Neurochemistry 2014; 128(6) doi: 10.1111/jnc.12516
18
Patricia P. Bloom, Elliot B. Tapper, Vincent B. Young, Anna S. Lok. Microbiome therapeutics for hepatic encephalopathy. Journal of Hepatology 2021; 75(6) doi: 10.1016/j.jhep.2021.08.004
19
Felipe Toyama Aires, Paola Teruya Ramos, Wanderley Marques Bernardo. Efficacy of lactulose in the prophylaxis of hepatic encephalopathy in cirrhotic patients presenting gastrointestinal bleeding. Revista da Associação Médica Brasileira 2016; 62(3) doi: 10.1590/1806-9282.62.03.243
20
Noriaki Naeshiro, Hideaki Kakizawa, Hiroshi Aikata, Hiromi Kan, Hatsue Fujino, Takayuki Fukuhara, Tomoki Kobayashi, Yohji Honda, Daisuke Miyaki, Tomokazu Kawaoka, Masataka Tsuge, Akira Hiramatsu, Michio Imamura, Yoshiiku Kawakami, Hideyuki Hyogo, Masaki Ishikawa, Kazuo Awai, Kazuaki Chayama. Percutaneous transvenous embolization for portosystemic shunts associated with encephalopathy: Long‐term outcomes in 14 patients. Hepatology Research 2014; 44(7) doi: 10.1111/hepr.12181
21
Herbert L. DuPont. Therapeutic Effects and Mechanisms of Action of Rifaximin in Gastrointestinal Diseases. Mayo Clinic Proceedings 2015; 90(8) doi: 10.1016/j.mayocp.2015.04.016
22
Sung-Min Won, Eunju Park, Jin-Ju Jeong, Raja Ganesan, Haripriya Gupta, Yoseph Gebru, SatyaPriya Sharma, Dong-Joon Kim, Ki-Tae Suk. The Gut Microbiota-Derived Immune Response in Chronic Liver Disease. International Journal of Molecular Sciences 2021; 22(15) doi: 10.3390/ijms22158309
23
Kakulavarapu V. Rama Rao, Arumugam R. Jayakumar, Michael D. Norenberg. Brain edema in acute liver failure: mechanisms and concepts. Metabolic Brain Disease 2014; 29(4) doi: 10.1007/s11011-014-9502-y
24
Michael W. Rowley, Myunghan Choi, Steve Chen, Kevin Hirsch, Anil B. Seetharam. Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision. CardioVascular and Interventional Radiology 2018; 41(11) doi: 10.1007/s00270-018-1992-2
25
Michael W. Rowley, Myunghan Choi, Steve Chen, Kevin Hirsch, Anil B. Seetharam. Race and Gradient Difference Are Associated with Increased Risk of Hepatic Encephalopathy Hospital Admission After Transjugular Intrahepatic Portosystemic Shunt Placement. Journal of Clinical and Experimental Hepatology 2018; 8(3) doi: 10.1016/j.jceh.2017.12.003
26
Makoto Usami, Makoto Miyoshi, Hayato Yamashita. Gut microbiota and host metabolism in liver cirrhosis. World Journal of Gastroenterology 2015; 21(41): 11597-11608 doi: 10.3748/wjg.v21.i41.11597
27
Michelle Spaan, Ellen Werner, Willemijn Dijkstra, Nicole E. Erler, Diederik Bijdevaate, Sarwa Darwish Murad, Milan J. Sonneveld, Caroline M. den Hoed, Anne van Eldere, Dave S. Sprengers, Willem‐Pieter Brouwer, Robert J. de Knegt, Harry L. A. Janssen, Kay Pieterman, Sandra Coenen, Raoel Maan, Adriaan J. van der Meer. Diabetes Mellitus is a Risk Factor for Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt. Alimentary Pharmacology & Therapeutics 2026; 63(7) doi: 10.1111/apt.70453
28
Poonam Sahu, Trilochan Satapathy. The Gut-Liver Axis in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Mechanisms, Microbiome Interactions and Therapeutic Targets. Probiotics and Antimicrobial Proteins 2026;  doi: 10.1007/s12602-026-11050-6
29
Fengfei Sun, Junfeng Chen, Kai Liu, Meizhen Tang, Yuewei Yang. The avian gut microbiota: Diversity, influencing factors, and future directions. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.934272
30
Andrew G. Taylor, Kanti P. Kolli, Robert K. Kerlan. Techniques for Transjugular Intrahepatic Portosystemic Shunt Reduction and Occlusion. Techniques in Vascular and Interventional Radiology 2016; 19(1) doi: 10.1053/j.tvir.2016.01.008
31
Mudassar Mohiuddin, Tayyaba Asghar, Hira Hameed, Ayesha Mohiud Din, Abubakar Siddique, Shahida Younas, Memona Mohi ud din, Roshan Ara. The psychobiotic revolution: comprehending the optimistic role of gut microbiota on gut-brain axis during neurological and Gastrointestinal (GI) disorders. World Journal of Microbiology and Biotechnology 2025; 41(10) doi: 10.1007/s11274-025-04632-z
32
G. Vassallo, A. Mirijello, A. Ferrulli, M. Antonelli, R. Landolfi, A. Gasbarrini, G. Addolorato. Review article: alcohol and gut microbiota ‐ the possible role of gut microbiota modulation in the treatment of alcoholic liver disease. Alimentary Pharmacology & Therapeutics 2015; 41(10) doi: 10.1111/apt.13164
33
Eamonn M Quigley, Howard P Monsour. The gut microbiota and the liver: implications for clinical practice. Expert Review of Gastroenterology & Hepatology 2013; 7(8) doi: 10.1586/17474124.2013.848167
34
Rahul Rai, Vivek A. Saraswat, Radha K. Dhiman. Gut Microbiota: Its Role in Hepatic Encephalopathy. Journal of Clinical and Experimental Hepatology 2015; 5 doi: 10.1016/j.jceh.2014.12.003
35
Daniela Campion, Ilaria Giovo, Paola Ponzo, Giorgio M Saracco, Federico Balzola, Carlo Alessandria. Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis. World Journal of Hepatology 2019; 11(6): 489-512 doi: 10.4254/wjh.v11.i6.489
36
Leon Louis Seifert, Philipp Schindler, Martin Schoster, Jan Frederic Weller, Christian Wilms, Hartmut H. Schmidt, Miriam Maschmeier, Max Masthoff, Michael Köhler, Hauke Heinzow, Moritz Wildgruber. Recurrence of Hepatic Encephalopathy after TIPS: Effective Prophylaxis with Combination of Lactulose and Rifaximin. Journal of Clinical Medicine 2021; 10(20) doi: 10.3390/jcm10204763
37
Lucia Giuli, Marta Maestri, Francesco Santopaolo, Maurizio Pompili, Francesca Romana Ponziani. Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease. Metabolites 2023; 13(6) doi: 10.3390/metabo13060772
38
Wu-Kui Cao, Jian-Yang Guo, Ming Luo. Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis. World Journal of Gastroenterology 2015; 21(41): 11815-11824 doi: 10.3748/wjg.v21.i41.11815
39
Tamalika Chakraborty, Jeenatara Begum, Dipanjan Mandal, Abhijit Sengupta. Advances in Probiotics. 2021;  doi: 10.1016/B978-0-12-822909-5.00013-7
40
Jing Li, Lu Zheng, Nan You, Xiao-Bing Huang, Yu Zhang, Wei-Wei Wang. Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction. World Journal of Gastroenterology 2017; 23(38): 6983-6994 doi: 10.3748/wjg.v23.i38.6983
41
Ramzi Hassouneh, Jasmohan S. Bajaj. Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment. Journal of Clinical Medicine 2021; 10(2) doi: 10.3390/jcm10020330
42
Rohan Dalal, Richard G McGee, Stephen M Riordan, Angela C Webster. Probiotics for people with hepatic encephalopathy. Cochrane Database of Systematic Reviews 2017; 2021(1) doi: 10.1002/14651858.CD008716.pub3
43
Alberto Nicoletti, Francesca Romana Ponziani, Marco Biolato, Venanzio Valenza, Giuseppe Marrone, Gabriele Sganga, Antonio Gasbarrini, Luca Miele, Antonio Grieco. Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation. World Journal of Gastroenterology 2019; 25(33): 4814-4834 doi: 10.3748/wjg.v25.i33.4814
44
Cinzia Signorini, Claudio De Felice, Silvia Leoncini, Thierry Durand, Jean-Marie Galano, Alessio Cortelazzo, Gloria Zollo, Roberto Guerranti, Stefano Gonnelli, Carla Caffarelli, Marcello Rossi, Alessandra Pecorelli, Giuseppe Valacchi, Lucia Ciccoli, Joussef Hayek. Altered erythrocyte membrane fatty acid profile in typical Rett syndrome: Effects of omega-3 polyunsaturated fatty acid supplementation. Prostaglandins, Leukotrienes and Essential Fatty Acids 2014; 91(5) doi: 10.1016/j.plefa.2014.08.002
45
Ahmed A. Sedik, Renad Alrefaei. New insight on hepatic encephalopathy: a comprehensive review. Journal of Basic and Clinical Physiology and Pharmacology 2026;  doi: 10.1515/jbcpp-2025-0166
46
Leigh C. Casadaban, Ahmad Parvinian, Jeet Minocha, Janesh Lakhoo, Christopher W. Grant, Charles E. Ray, M. Grace Knuttinen, James T. Bui, Ron C. Gaba. Clearing the Confusion over Hepatic Encephalopathy After TIPS Creation: Incidence, Prognostic Factors, and Clinical Outcomes. Digestive Diseases and Sciences 2015; 60(4) doi: 10.1007/s10620-014-3391-0
47
Stephen D. H. Malnick, David Fisher, Marina Somin, Manuela G. Neuman. Treating the Metabolic Syndrome by Fecal Transplantation—Current Status. Biology 2021; 10(5) doi: 10.3390/biology10050447
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.